0001104659-17-050275.txt : 20170808 0001104659-17-050275.hdr.sgml : 20170808 20170808162412 ACCESSION NUMBER: 0001104659-17-050275 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170804 FILED AS OF DATE: 20170808 DATE AS OF CHANGE: 20170808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Golubieski John CENTRAL INDEX KEY: 0001610695 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37635 FILM NUMBER: 171015123 MAIL ADDRESS: STREET 1: C/O LANTHEUS HOLDINGS, INC. STREET 2: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: NY ZIP: 01862 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25 BROADWAY, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 BUSINESS PHONE: 212-203-5072 MAIL ADDRESS: STREET 1: 25 BROADWAY, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 3 1 a3.xml 3 X0206 3 2017-08-04 1 0001579428 Axsome Therapeutics, Inc. AXSM 0001610695 Golubieski John 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 0 1 0 0 Chief Financial Officer /s/ John Golubieski 2017-08-08